Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126347833 | 12634783 | 3 | F | 20160723 | 20160831 | 20160809 | 20160909 | EXP | JP-JNJFOC-20160805524 | JANSSEN | 74.55 | YR | E | M | Y | 64.00000 | KG | 20160909 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126347833 | 12634783 | 1 | PS | ZYTIGA | ABIRATERONE ACETATE | 1 | Oral | IN THE MORNING | Y | N | 202379 | 1000 | MG | TABLET | QD | ||||
| 126347833 | 12634783 | 2 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | ORAL ( IN THE MORNING AND AT NOON ) | Y | 0 | 5 | MG | TABLET | BID | |||||
| 126347833 | 12634783 | 3 | C | EQUA | VILDAGLIPTIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 4 | C | CARBAZOCHROME SODIUM SULFONATE | CARBAZOCHROME SODIUM SULFONATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 5 | C | FLIVAS | NAFTOPIDIL | 1 | Oral | 0 | 75 | MG | TABLET | QD | |||||||
| 126347833 | 12634783 | 6 | C | ALDACTONE A | SPIRONOLACTONE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 7 | C | LASIX | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 0 | INJECTION | ||||||||||
| 126347833 | 12634783 | 8 | C | LIVALO | PITAVASTATIN CALCIUM | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 9 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 10 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 11 | C | LIXIANA | EDOXABAN TOSILATE MONOHYDRATE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 12 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126347833 | 12634783 | 13 | C | VALSARTAN. | VALSARTAN | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126347833 | 12634783 | 1 | Prostate cancer |
| 126347833 | 12634783 | 2 | Prostate cancer |
| 126347833 | 12634783 | 3 | Diabetes mellitus |
| 126347833 | 12634783 | 4 | Product used for unknown indication |
| 126347833 | 12634783 | 5 | Benign prostatic hyperplasia |
| 126347833 | 12634783 | 6 | Cardiac failure |
| 126347833 | 12634783 | 7 | Cardiac failure |
| 126347833 | 12634783 | 8 | Dyslipidaemia |
| 126347833 | 12634783 | 9 | Diabetes mellitus |
| 126347833 | 12634783 | 10 | Diabetes mellitus |
| 126347833 | 12634783 | 11 | Venous thrombosis |
| 126347833 | 12634783 | 12 | Anaemia |
| 126347833 | 12634783 | 13 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126347833 | 12634783 | OT |
| 126347833 | 12634783 | HO |
| 126347833 | 12634783 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126347833 | 12634783 | Cardiac failure | |
| 126347833 | 12634783 | Cerebral infarction | |
| 126347833 | 12634783 | Diabetic ketoacidosis | |
| 126347833 | 12634783 | Pyrexia | |
| 126347833 | 12634783 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126347833 | 12634783 | 1 | 20160722 | 20160723 | 0 | |
| 126347833 | 12634783 | 2 | 20160722 | 20160723 | 0 | |
| 126347833 | 12634783 | 5 | 20141122 | 0 | ||
| 126347833 | 12634783 | 13 | 20120413 | 0 |